stats
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC).
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC).
AUA 2024, Upper Tract Urothelial Cancer (UTUC), UGN-101, UGN-101 for Upper Tract Urothelial Cancer, Jelmyto, OLYMPUS trial, Chemoablation, reteral tumors, pelvicalyceal tumors, endoscopic ablation.
AUA 2024, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), prostate cancer, staging recurrent prostate cancer, timeline of FDA approvals of molecular imaging agents for…
AUA 2024, Non–muscle-Invasive Bladder Cancer (NMIBC), TAR-210, erdafitinib, MoonRISe-1 study, FGFR Alterations, tyrosine kinase inhibitor, gemcitabine.
AUA 2024, Upper Tract Urothelial Carcinoma, bladder cancer, urothelial carcinoma, white light cystoscopy, oral 5-aminolevulinic acid (ALA), Photodynamic Diagnosis( PDD), Diagnostic Performance of Photodynamic Diagnosis…
AUA 2024, Orthotopic Neobladder, Orthotopic Neobladder After Radical Cystectomy, Impairment of Quality of Life Due to a Orthotopic Neobladder After Radical Cystectomy, ileal orthotopic neobladder.
Community notes were accurate and cited mostly credible sources, researchers say
AUA 2024 SWOG S1011 trial assessing national performance of lymphadenectomy for muscle-invasive urothelial cancer, radical cystectomy, cT2-4aN0-2 urothelial cancer.
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care…
AUA 2024 prostate cancer detection and screening, Decipher® score, radical prostatectomy pathology, Decipher® genomic classifier, Decipher® testing on prostate biopsy.
AUA 2024, metastatic hormone-sensitive prostate cancer (mHSPC), Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), androgen deprivation therapy (ADT), androgen receptor pathway inhibitor (ARPI), androgen…